Replimune (REPL) Other Operating Expenses (2021 - 2026)
Replimune's Other Operating Expenses was $33.22 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 42.0% from $57.27 million a year earlier and down 31.6% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Other Operating Expenses (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's Other Operating Expenses was $187.25 million through Sep 30, 2026, down 13.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $221 million, up 16.7% from FY2025.
- Other Operating Expenses has now increased for nine consecutive fiscal years, with a five-year compound annual growth rate of 32.4% (FY2021 to FY2026).
- In earlier fiscal years, Other Operating Expenses was $189.45 million in FY2025 (+8.3%), $174.96 million in FY2024 (+38.3%), $126.53 million in FY2023 (+64.1%) and $77.12 million in FY2022 (+42.0%).
- The fiscal Q2 2027 figure marks the lowest quarterly Other Operating Expenses since fiscal Q3 2023.
- Compared with a year earlier, Other Operating Expenses has declined for three straight quarters, with growth averaging 7.3% over the last eight quarters.
- The best year-over-year quarter for Other Operating Expenses over five years was fiscal Q4 2023 (growth of 79.6%); the worst was fiscal Q2 2027 (a decline of 42.0%).
- Per Business Quant data, REPL's Other Operating Expenses in the three fiscal quarters before Q2 2027 was $48.56 million (Q1 2027), $52.32 million (Q4 2026) and $53.14 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -896,000.00 |
| Jun 30, 2026 | -896,000.00 |
| Sep 30, 2025 | -897,000.00 |
| Jun 30, 2025 | -895,000.00 |
| Sep 30, 2024 | -892,000.00 |
| Jun 30, 2024 | -888,000.00 |
| Dec 31, 2022 | -859,000.00 |
| Sep 30, 2022 | -859,000.00 |
| Jun 30, 2022 | -866,000.00 |
| Mar 31, 2022 | -874,000.00 |
| Dec 31, 2021 | -856,000.00 |
| Sep 30, 2021 | -852,000.00 |
| Jun 30, 2021 | -849,000.00 |
API Access
Replimune Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();